INTERGRATED DIA.H DL 025 Market Cap ($251.46 Million)
Market Cap & Net Worth: INTERGRATED DIA.H DL 025 (8I8)
INTERGRATED DIA.H DL 025 market cap. INTERGRATED DIA.H DL 025 (F:8I8) has a market capitalization of $251.46 Million (€215.09 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #15406 globally and #1504 in its home market, demonstrating a -7.04% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INTERGRATED DIA.H DL 025's stock price €0.37 by its total outstanding shares 581326272 (581.33 Million). Also see 8I8 cash flow conversion for how efficiently the company converts equity into cash flow.
INTERGRATED DIA.H DL 025 Market Cap History (2021–2026)
INTERGRATED DIA.H DL 025 market cap history from 2021 to 2026. Data shows change from $648.50 Million to $251.46 Million (-9.81% CAGR). Check INTERGRATED DIA.H DL 025 (8I8) share price today for real-time trading data and today's change.
INTERGRATED DIA.H DL 025 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INTERGRATED DIA.H DL 025's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is INTERGRATED DIA.H DL 025 growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.05x
INTERGRATED DIA.H DL 025's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.30x
INTERGRATED DIA.H DL 025's market cap is 0.30 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $648.50 Million | $5.22 Billion | $1.41 Billion | 0.12x | 0.46x |
| 2022 | $387.39 Million | $3.61 Billion | $541.11 Million | 0.11x | 0.72x |
| 2023 | $194.37 Million | $4.12 Billion | $510.30 Million | 0.05x | 0.38x |
| 2024 | $256.90 Million | $5.72 Billion | $1.08 Billion | 0.04x | 0.24x |
| 2025 | $383.99 Million | $7.86 Billion | $1.26 Billion | 0.05x | 0.30x |
Competitor Companies of 8I8 by Market Capitalization
Companies near INTERGRATED DIA.H DL 025 in the global market cap rankings as of November 4, 2026. Also see INTERGRATED DIA.H DL 025 (8I8) total assets for a full breakdown of the balance sheet.
Key companies related to INTERGRATED DIA.H DL 025 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $161.03 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #493 globally with a market cap of $54.62 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #539 globally with a market cap of $50.18 Billion USD ( CN¥342.92 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $682.65 |
| #143 | Danaher Corporation | NYSE:DHR | $161.03 Billion | $227.97 |
| #493 | Natera Inc | NASDAQ:NTRA | $54.62 Billion | $378.92 |
| #539 | WuXi AppTec Co Ltd | SHG:603259 | $50.18 Billion | CN¥138.65 |
Market Capitalization of INTERGRATED DIA.H DL 025 (2021–2026)
Market capitalization of INTERGRATED DIA.H DL 025 from 2021 to today. Between 2021 and today, INTERGRATED DIA.H DL 025's market cap moved from $648.50 Million to $ 251.46 Million, with a yearly change of -9.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €251.46 Million | -34.51% |
| 2025 | €383.99 Million | +49.47% |
| 2024 | €256.90 Million | +32.17% |
| 2023 | €194.37 Million | -49.82% |
| 2022 | €387.39 Million | -40.26% |
| 2021 | €648.50 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of INTERGRATED DIA.H DL 025 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $251.46 Million USD |
| MoneyControl | $251.46 Million USD |
| MarketWatch | $251.46 Million USD |
| marketcap.company | $251.46 Million USD |
| Reuters | $251.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About INTERGRATED DIA.H DL 025
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more